# Patients With Intermittent Claudication Injected With ALDH Bright Cells

> **NCT01774097** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 82 (actual)

## Conditions studied

- Peripheral Artery Disease
- Intermittent Claudication

## Interventions

- **BIOLOGICAL:** ALD-301
- **BIOLOGICAL:** Placebo (vehicle)

## Key facts

- **NCT ID:** NCT01774097
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-08
- **Final completion:** 2017-03
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2017-04-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01774097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01774097, "Patients With Intermittent Claudication Injected With ALDH Bright Cells". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01774097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*